½ÃÀ庸°í¼­
»óǰÄÚµå
1593039

¼¼°èÀÇ Á¤¸Æ³» ½Ã½ºÅÛ ¾×¼¼½º µð¹ÙÀ̽º ½ÃÀå : Á¦Ç° À¯Çü, Åõ¿© °æ·Î, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Intravenous System Access Devices Market by Product Type (Central Catheter, Peripheral Catheter), Route of Administration (Intravenous, Subcutaneous), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 182 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Á¤¸Æ³» ½Ã½ºÅÛ ¾×¼¼½º µð¹ÙÀ̽º ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 194¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 209¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.85%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 330¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¤¸Æ³» ½Ã½ºÅÛ ¾×¼¼½º µð¹ÙÀ̽º´Â °Ç°­ °ü¸®¿¡ ÇʼöÀûÀÎ µµ±¸ÀÌ¸ç ¾à¹°, ¿µ¾ç¼Ò ¹× ±âŸ ¼öºÐÀ» Ç÷·ù¿¡ Á÷Á¢ Åõ¿© ÇÒ ¼öÀÖ°ÔÇÕ´Ï´Ù. ½Å¼ÓÇÑ ¾à¹° Àü´ÞÀÌ °¡Àå Áß¿äÇÑ È­ÇÐ ¿ä¹ý°ú °°Àº Àå±â Ä¡·á¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ¼öÇàÇϱ⠶§¹®¿¡ ¹ß»ýÇÕ´Ï´Ù. ÇÊ¿ä ȯÀÚ¿¡°Ô »ç¿ëµË´Ï´Ù. ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§´Â ³Ð°í ¾ÈÀüÇϰí È¿À²ÀûÀÎ ¾à¹° Åõ¿©°¡ ÇʼöÀûÀÎ ³ëÀÎ ÀÇ·á, ¼Ò¾Æ ÀÇ·á ¹× ¼ºÀÎ ÀÇ·á ºÐ¾ßÀÇ ¿ëµµ¸¦ Æ÷ÇÔÇÕ´Ï´Ù. È­, ¸¸¼º Áúȯ Áõ°¡, ÀÇ·á±â±âÀÇ ±â¼ú Áøº¸°¡ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀÔ´Ï´Ù.¶ÇÇÑ, ³·Àº ħ½À óġ·ÎÀÇ ½ÃÇÁÆ®°¡ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ¾î ½ÅÈï ½ÃÀåÀ̳ª ±â±âÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀÇ Çõ½Å¿¡ ÀáÀçÀûÀÎ ±âȸ¸¦ º¼ ¼ö ÀÖ½À´Ï´Ù. ½º¸¶Æ® Á¡Àû ½Ã½ºÅÛ ¹× °³·®Çü ¹ÙÀÌ¿À¼¼ ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ´Â ÇʼöÀûÀÔ´Ï´Ù. ±×·¯³ª °íºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ȯ°æ, °¨¿° À§Çè µîÀÇ Á¦¾àÀÌ Å« °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶Ç´Â Ȩ ÄÉ¾î ¸µ °æ°è¿¡¼­ Àåºñ °ü¸®ÀÇ º¹À⼺°ú °ü·ÃµÈ ¹®Á¦°¡ ÀÖ½À´Ï´Ù. ºñÁî´Ï½º ¼ºÀå¿¡ ´ëÇÑ ±æÀº ±â¼ú Çõ½Å, ƯÈ÷ ȯÀÚ ¾ÈÀü ±â´É °­È­, ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç °³¹ß ¹× ±¹Á¦ Ç¥ÁØ Áؼö¸¦ ´Þ¼ºÇÏ´Â °ÍÀÔ´Ï´Ù. ¶Ç´Â ¸ð´ÏÅ͸µÀ»À§ÇÑ °³ÀÎÈ­ ¹× ÀΰøÁö´É¿¡ ´ëÇÑ ÅõÀڴ ȯÀÚÀÇ °á°ú¿¡ Çõ¸íÀ» °¡Á®¿Í °æÀï ¿ìÀ§¸¦ À¯ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ Æ¯¼ºÀº ¿ªµ¿ÀûÀÌ°í °æÀïÀûÀ̸ç ȯÀÚ Áß½ÉÀÇ °ü¸®¿Í ±â¼ú ÅëÇÕ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °Ç°­ °ü¸® Á¦°ø¾÷ü¿ÍÀÇ Çù·Â°ú Áö¼ÓÀûÀÎ Çõ½ÅÀ» ¼±È£ÇÏ´Â ±â¾÷Àº »õ·Î¿î µ¿ÇâÀ» Ȱ¿ëÇϰíÀÌ Áß¿äÇÑ °Ç°­ °ü¸® ºÐ¾ß¿¡¼­ Àå±âÀûÀÎ ¼ºÀåÀ» À¯ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 194¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 209¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 330¾ï ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 7.85%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â Á¤¸Æ³» ½Ã½ºÅÛ Á¢±Ù ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Á¤¸Æ ³» ½Ã½ºÅÛ ¾×¼¼½º ÀåÄ¡ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. °áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÉÇ÷°ü ÁúȯÀÇ ÀÌȯÀ²°ú ´ç´¢º´ÀÇ À¯º´·üÀÇ »ó½Â
    • ¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡
    • Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ±âÈ£
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼÷·ÃµÈ °æÇè dzºÎÇÑ ÇコÄɾî Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ±âȸ
    • ÇコÄÉ¾î ºÎ¹®¿¡ ´ëÇÑ ÅõÀÚ
    • »õ·Î¿î ±â±âÀÇ Çõ½Å
  • ½ÃÀåÀÇ °úÁ¦
    • ¸ñ¿å ¾×¼¼½º ÀåºñÀÇ ÇÕº´Áõ ¹®Á¦ ÇØ°á

Porter's Five Forces : Á¤¸Æ ³» ½Ã½ºÅÛ ¾×¼¼½º ÀåÄ¡ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Á¤¸Æ ³» ½Ã½ºÅÛ ¾×¼¼½º ÀåÄ¡ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Á¤¸Æ ³» ½Ã½ºÅÛ ¾×¼¼½º ÀåÄ¡ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Á¤¸Æ ³» ½Ã½ºÅÛ ¾×¼¼½º ÀåÄ¡ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Á¤¸Æ ³» ½Ã½ºÅÛ ¾×¼¼½º ÀåÄ¡ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Á¤¸Æ ³» ½Ã½ºÅÛ ¾×¼¼½º ÀåÄ¡ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Á¤¸Æ ³» ½Ã½ºÅÛ ¾×¼¼½º Àåºñ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå Á¤¸Æ ³» ½Ã½ºÅÛ ¾×¼¼½º ÀåÄ¡ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

Á¤¸Æ ³» ½Ã½ºÅÛ ¾×¼¼½º ÀåÄ¡ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀ» »ç¿ëÇÏ¸é °æÀï ±¸µµ¿¡¼­ ¾î·Á¿òÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ½ÉÇ÷°ü ÁúȯÀÇ ¹ßº´·ü°ú ´ç´¢º´ÀÇ À¯º´·üÀÇ »ó½Â
      • ¿Ü°ú ¼ö¼ú Áõ°¡
      • Àúħ½À ¼ö¼úÀ» ¿ì¼±
    • ¾ïÁ¦¿äÀÎ
      • ¼÷·ÃµÈ °æÇè dzºÎÇÑ ÇコÄɾî Àü¹®°¡ÀÇ ºÎÁ·
    • ±âȸ
      • ÇコÄÉ¾î ºÐ¾ß¿¡ ´ëÇÑ ÅõÀÚ
      • »õ·Î¿î µð¹ÙÀ̽ºÀÇ Çõ½Å
    • °úÁ¦
      • Ç÷°ü Á¢±Ù ÀåÄ¡ÀÇ ÇÕº´Áõ ¹®Á¦ ÇØ°á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Á¤¸Æ³» ½Ã½ºÅÛ ¾×¼¼½º µð¹ÙÀ̽º ½ÃÀå : Á¦Ç° À¯Çüº°

  • Á᫐ Á¤¸Æ Ä«Å×ÅÍ
    • ¾×¼¼¼­¸®
    • VC
    • Åõ¼® Ä«Å×ÅÍ
    • ¸Å¸³Çü Ä«Å×ÅÍ
    • PICC
  • ¸»ÃÊ Ä«Å×ÅÍ
    • Á¤Áß¼± Ä«Å×ÅÍ
    • PIV Ä«Å×ÅÍ

Á¦7Àå Á¤¸Æ³» ½Ã½ºÅÛ ¾×¼¼½º µð¹ÙÀ̽º ½ÃÀå : Åõ¿© °æ·Îº°

  • Á¤¸Æ³»
  • ÇÇÇÏ

Á¦8Àå Á¤¸Æ³» ½Ã½ºÅÛ ¾×¼¼½º µð¹ÙÀ̽º ½ÃÀå : ¿ëµµº°

  • ¼öºÐ°ú ¿µ¾ç¼ÒÀÇ Åõ¿©
  • Áø´Ü °Ë»ç
  • Åõ¾à °ü¸®
  • Ç÷¾×Á¦Á¦ÀÇ ¼öÇ÷

Á¦9Àå Á¤¸Æ³» ½Ã½ºÅÛ ¾×¼¼½º µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Á¤¸Æ³» ½Ã½ºÅÛ ¾×¼¼½º µð¹ÙÀ̽º ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Á¤¸Æ³» ½Ã½ºÅÛ ¾×¼¼½º µð¹ÙÀ̽º ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Á¤¸Æ³» ½Ã½ºÅÛ ¾×¼¼½º µð¹ÙÀ̽º ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Baxter Internationa
  • Becton, Dickinson & Company
  • Braun Melsungen AG
  • CareFusion Corporation
  • Covidien Plc
  • Fresenius Medical Care Ag & Co
  • Medtronic, Inc.
  • Merck KGaA
  • Smiths Medical
  • Teleflex Incorporated
BJH 24.11.22

The Intravenous System Access Devices Market was valued at USD 19.43 billion in 2023, expected to reach USD 20.94 billion in 2024, and is projected to grow at a CAGR of 7.85%, to USD 33.00 billion by 2030.

Intravenous system access devices are essential tools in healthcare, allowing for direct administration of medications, nutrients, and other fluids into the bloodstream. Necessity arises from their pivotal role in critical care, emergencies, and long-term therapies such as chemotherapy, where precise and swift drug delivery is paramount. These devices find applications across hospitals, clinics, and home care settings, catering to patients with chronic illnesses, trauma, or surgical needs. The end-use scope is broad, including applications in geriatrics, pediatrics, and adult care where safe and efficient medication administration is essential. Market insights reveal that the aging population, an increase in chronic diseases, and technological advancements in medical devices are key growth drivers. Additionally, the shift towards minimally invasive procedures boosts market expansion, with potential opportunities seen in emerging markets and innovations in device safety and efficacy. The development of smart IV systems and improved biosensors presents substantial potential; hence, investment in research and development is vital. However, limitations such as high costs, stringent regulatory environments, and risks of infections pose significant challenges. There are also issues related to skilled workforce shortages and the complexity of device management in home care settings. The path to business growth lies in innovation, especially in enhancing patient safety features, developing cost-effective solutions, and achieving compliance with international standards. Investing in personalization and artificial intelligence for predictive maintenance and monitoring can revolutionize patient outcomes and maintain competitive advantage. The nature of the market is dynamic and competitive, with an increasing focus on patient-centered care and technology integration. Companies that prioritize collaboration with healthcare providers and continuous innovation are poised to capitalize on emerging trends and sustain long-term growth in this crucial healthcare segment.

KEY MARKET STATISTICS
Base Year [2023] USD 19.43 billion
Estimated Year [2024] USD 20.94 billion
Forecast Year [2030] USD 33.00 billion
CAGR (%) 7.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravenous System Access Devices Market

The Intravenous System Access Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of cardiovascular disease and prevalence of diabetes
    • Growing number of surgical procedures
    • Preference for minimally invasive procedures
  • Market Restraints
    • Limited availability of skilled & experienced healthcare professionals
  • Market Opportunities
    • Investment in the healthcare sector
    • Innovations in the new devices
  • Market Challenges
    • Troubleshooting complications of vascular access devices

Porter's Five Forces: A Strategic Tool for Navigating the Intravenous System Access Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravenous System Access Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravenous System Access Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravenous System Access Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravenous System Access Devices Market

A detailed market share analysis in the Intravenous System Access Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravenous System Access Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravenous System Access Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravenous System Access Devices Market

A strategic analysis of the Intravenous System Access Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravenous System Access Devices Market, highlighting leading vendors and their innovative profiles. These include Baxter Internationa, Becton, Dickinson & Company, Braun Melsungen AG, CareFusion Corporation, Covidien Plc, Fresenius Medical Care Ag & Co, Medtronic, Inc., Merck KGaA, Smiths Medical, and Teleflex Incorporated.

Market Segmentation & Coverage

This research report categorizes the Intravenous System Access Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Central Catheter and Peripheral Catheter. The Central Catheter is further studied across Accessories, CVC, Dialysis Catheter, Implantable Catheter, and PICC. The Peripheral Catheter is further studied across Midline Catheter and PIV Catheter.
  • Based on Route of Administration, market is studied across Intravenous and Subcutaneous.
  • Based on Application, market is studied across Administration of Fluids & Nutrients, Diagnostic Testing, Medication Administration, and Transfusion of Blood Products.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of cardiovascular disease and prevalence of diabetes
      • 5.1.1.2. Growing number of surgical procedures
      • 5.1.1.3. Preference for minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled & experienced healthcare professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Investment in the healthcare sector
      • 5.1.3.2. Innovations in the new devices
    • 5.1.4. Challenges
      • 5.1.4.1. Troubleshooting complications of vascular access devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intravenous System Access Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Central Catheter
    • 6.2.1. Accessories
    • 6.2.2. CVC
    • 6.2.3. Dialysis Catheter
    • 6.2.4. Implantable Catheter
    • 6.2.5. PICC
  • 6.3. Peripheral Catheter
    • 6.3.1. Midline Catheter
    • 6.3.2. PIV Catheter

7. Intravenous System Access Devices Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Intravenous
  • 7.3. Subcutaneous

8. Intravenous System Access Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Administration of Fluids & Nutrients
  • 8.3. Diagnostic Testing
  • 8.4. Medication Administration
  • 8.5. Transfusion of Blood Products

9. Intravenous System Access Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Clinics
  • 9.4. Hospitals

10. Americas Intravenous System Access Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Intravenous System Access Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Intravenous System Access Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Baxter Internationa
  • 2. Becton, Dickinson & Company
  • 3. Braun Melsungen AG
  • 4. CareFusion Corporation
  • 5. Covidien Plc
  • 6. Fresenius Medical Care Ag & Co
  • 7. Medtronic, Inc.
  • 8. Merck KGaA
  • 9. Smiths Medical
  • 10. Teleflex Incorporated
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦